Erythropoietin for traumatic brain injury--reply
- PMID: 25387194
- PMCID: PMC4462129
- DOI: 10.1001/jama.2014.12744
Erythropoietin for traumatic brain injury--reply
Conflict of interest statement
Comment on
-
Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial.JAMA. 2014 Jul 2;312(1):36-47. doi: 10.1001/jama.2014.6490. JAMA. 2014. PMID: 25058216 Free PMC article. Clinical Trial.
-
Erythropoietin for traumatic brain injury.JAMA. 2014 Nov 12;312(18):1928-9. doi: 10.1001/jama.2014.12738. JAMA. 2014. PMID: 25387193 No abstract available.
References
-
- Talving P, Lustenberger T, Kobayashi L, et al. Erythropoiesis stimulating agent administration improves survival after severe traumatic brain injury: a matched case control study. Ann Surg. 2010;251(1):1–4. - PubMed
-
- Talving P, Lustenberger T, Inaba K, et al. Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. Arch Surg. 2012;147(3):251–255. - PubMed
-
- Napolitano LM, Fabian TC, Kelly KM, et al. Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. J Trauma. 2008;65(2):285–299. - PubMed
-
- Palesch YY, Tilley BC, Sackett DL, Johnston KC, Woolson R. Applying a phase II futility study design to therapeutic stroke trials. Stroke. 2005;36(11):2410–2414. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
